{
    "2019-07-18": [
        [
            {
                "time": "",
                "original_text": "贝达药业状告创始股东，或也暴露当年上市时的信披违规 诉讼纠纷",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "创始股东",
                        "信披违规",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业:销量同比增长31.26%，在研管线推进顺利",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "销量增长",
                        "在研管线",
                        "推进顺利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}